# EDGAR Filing Document

**Accession Number:** 0001567831
**File Stem:** 0001562180-23-000054
**Filing Date:** 2023-1
**Character Count:** 8235
**Document Hash:** 5716ee6e3624cda8211670fa9466fa8d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-23-000054.hdr.sgml**: 20230103

**ACCESSION NUMBER**: 0001562180-23-000054

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221229

**FILED AS OF DATE**: 20230103

**DATE AS OF CHANGE**: 20230103

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lewis Clinton A. Jr.
- **CENTRAL INDEX KEY:** 0001567831

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36316
- **FILM NUMBER:** 23504115

**MAIL ADDRESS:**
- **STREET 1:** C/O ZOETIS INC.
- **STREET 2:** 100 CAMPUS DRIVE
- **CITY:** FLORHAM PARK
- **STATE:** NJ
- **ZIP:** 07940
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AgroFresh Solutions, Inc.
- **CENTRAL INDEX KEY:** 0001592016
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **IRS NUMBER:** 464007249
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 100 S. INDEPENDENCE MALL WEST
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106
- **BUSINESS PHONE:** 215-592-3687

**MAIL ADDRESS:**
- **STREET 1:** 100 S. INDEPENDENCE MALL WEST
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Boulevard Acquisition Corp.
- **DATE OF NAME CHANGE:** 20131114

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lewis Clinton A. Jr.<br><sub>(Last) (First) (Middle)</sub><br>ONE WASHINGTON SQUARE<br>510-530 WALNUT STREET, SUITE 1350<br><sub>(Street)</sub><br>PHILADELPHIA, PA 19106<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2022-12-29 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>AgroFresh Solutions, Inc. [ AGFS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2022-12-29 |  | F |  | 69761.00<sup>(1)</sup> | D | $2.96 | 338969.00<sup>(2)</sup> | D |  |
| Common Stock | 2022-12-29 |  | F |  | 60092.00<sup>(1)</sup> | D | $2.96 | 249770.00<sup>(3)</sup> | D |  |
| Common Stock | 2022-12-29 |  | F |  | 61776.00<sup>(1)</sup> | D | $2.96 | 256759.00<sup>(4)</sup> | D |  |
| Common Stock | 2022-12-29 |  | M |  | 181751.00<sup>(1)</sup> | A | $2.07 | 235201.00 | D |  |
| Common Stock | 2022-12-29 |  | F |  | 151652.00<sup>(1)</sup> | D | $2.95 | 83549.00 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | $2.07 | 2022-12-29 |  | M |  |  | 181751.00 | <sup>(5)</sup> | 2031-05-10 | Common Stock | 181751.00 | $0.00 | 363503.00 | D |  |

---

### Footnotes:

(1) On December 29, 2022, in order to mitigate or eliminate the amount of excise tax that might be payable by the Reporting Person in certain circumstances pursuant to Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended, the Board of Directors of the Issuer approved accelerated vesting of the Reporting Person's equity awards that were otherwise scheduled to vest in April and May of 2023, including service-based restricted stock units ("RSUs") with all such RSU accelerations occurring on December 29, 2022.

(2) The Reporting Person was granted 408,730 restricted shares in 2022, originally vesting in three equal annual installments beginning on April 1, 2023. 69,761 shares were forfeited effective December 29, 2022 in satisfaction of taxes payable upon accelerated vesting of the installment originally scheduled to vest on April 1, 2023.

(3) The Reporting Person was granted 352,444 restricted shares in 2021, originally vesting in three equal annual installments beginning on March 31, 2022. 60,092 shares were forfeited effective December 29, 2022 in satisfaction of taxes payable upon accelerated vesting of the installment originally scheduled to vest on March 31, 2023, and certain of these shares were previously forfeited in satisfaction of taxes payable upon vesting.  Shares reported in this row are in addition to shares reported in row 5, which are not subject to restrictions.

(4) The Reporting Person was granted 362,319 restricted shares in 2021, originally vesting in three equal annual installments beginning on May 10, 2022. 61,776 shares were forfeited effective December 29, 2022 in satisfaction of taxes payable upon accelerated vesting of the installment originally scheduled to vest on May 10, 2023, and certain of these shares were previously forfeited in satisfaction of taxes payable upon vesting.  Shares reported in this row are in addition to shares reported in row 5, which are not subject to restrictions.

(5) This stock option vests in three equal installments beginning on May 10, 2022.

**Signature:** /s/ Jason Simon, Attorney in Fact  
**Date:** 2023-01-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**